As we come to the end of 2011, we also come to the end of our year-long Defining Moments series. Once a month, all this year, we’ve looked back at the biggest events from exactly 12 months prior, and noticed how we can relate what’s been changing our world to what we can do in [...]
Tags:arsenic based life·communication·defining moments·digital strategy·Education·innovation·media·process·research·science·science and medicine·scientific journals·scientific research·technology·year in review
by Krissy Goelz (@krisgoelz)
How do you market the new hotness – when it is neither new nor hot anymore?
It’s a pressing issue for pharmaceutical companies, which have become increasingly dependent on blockbuster drugs (the equivalent of tentpole movies in the film industry) for long-term financial performance and market share.
But in a world bound by patents [...]
Tags:drug development·drug discovery & development·drug patents·drugs·marketing·patent·patents·Patients·Pharma·Pharmaceutical industry·research
by Krissy Goelz (@krisgoelz)
Anyone familiar with Discovery Channel’s hit show “Mythbusters” will know co-host Adam Savage’s catchphrase, “Failure is always an option.” As he explains, “It’s not just a joke, it’s actually the cornerstone of our approach to the scientific method. [...] Any result is a result.”
Science is used to the [...]
Tags:business·clinical trials·Education·fail·failure·Health·Health care·innovation·Pharmaceutical industry·R&D·research·strategy·technology·Trends·trials
By Dan Bobear (@dbobear)
Looking around the business landscape just a year or two ago, economic uncertainty lingered in the air. There was hesitancy as far as the eye can see. Whether the issue was hiring, funding a new initiative, putting money into product development or any one of countless other issues, the feeling from Wall [...]
Tags:business·competition·economic crisis·economy·framework·future·investment·manager·outcome·possibility·product development·research·risk·strategy·uncertainty
This post continues our series on Generation Y and their relationship with their health. From challenges to epidemics, this series attempts to expose how these digital natives are managing health-related issues, both individually and together.
By Bob Mason (@BobMasonPalio)
Attracting the youth market is critical for protecting the [...]
Tags:access·authenticity·brand advocate·communication·community·decision·digital·diligence·doctor·Generation Y·Health·information·marketing·millennial·mobile devices·motivation·online·parents·relationship·research·search·social media·technology
Today’s guest blog post is by Casey Williams, the Associate Director of Health Sciences at iProspect. Since joining the firm in 2006, Casey has focused on the health sciences market. She is responsible for strengthening relationships with iProspect’s clients in this field, and cultivating and disseminating health industry knowledge within iProspect and across its client [...]
Tags:audience·branding·content·Google·Health·information·marketing·media buy·Medicine·mobile·organic search·paid search·query·questions·research·search·search engine·service·strategy·traffic·treatment·update·visibility
The Defining Moments series looks back at the biggest events of 2010 to see what we can learn from them here at P&P, to work better in our calling, in 2011 and beyond.
By DJ Edgerton (@wiltonbound)
In May 2010, two of the biggest players in one of the biggest and most controversial industries joined forces. United [...]
Tags:airlines·change·competition·continental united·controversy·digital agency·drug discovery·finances·industry·maneuverability·merger·Mutiny Worldwide·network·pipeline·potential·prank·research·resources·savings·science·SoDA·strikes
This blog post is part of a crash-course series about the state of the healthcare industry, and the vital information that every pharma marketer needs to know.
By Rob Kempton (@manonthemooncon)
Social media is no longer the future – it’s here. Various stakeholders including patients, pharmaceutical companies, hospitals, medical practitioners and others are finding their voice in [...]
Tags:business·community·conversation·credibility·discussion·expectation·Hospital·influence·information·medical practitioner·Patients·personal·perspective·Pharma·research·responsibilities·social media·stakeholders
This post is part of a series of point/counterpoint arguments proposed by different members of the Pixels & Pills staff. We’re strong believers that healthy arguments can yield the best solutions, and we hope that you enjoy our series. Feel free to add your own arguments in the comments section below!
By Jim Mittler, PhD (@jim_mittler)
In [...]
Tags:activity·advocacy·awareness·Blog·condition·coping·decision·diagnosis·disease·doctor·empowered·game·health decisions·healthcare·Knowledge·lifestyle·manage disease·Patients·perspective·reminder·research·risks·social media·stress·terminology·treatment options·Twitter
Mike Keriakos, Co-Founder & President of Everyday Health, and Asaf Evenhaim, Co-Founder & CEO of Crossix, teamed up to measure the ROI of patient education centers and how the participants compare to the conversion rates of brand websites.
Tags:#dtc2011·Asaf Evenhaim·brand website·conference·Crossix·DTC National Convention·DTC Perspectives·events·Everyday Health·interview·Mike Keriakos·patient education·research·ROI·Video
